Sunesis Pharmaceuticals, Inc. (SNSS) Launches Phase 3 VALOR Trial for Vosaroxin Drug
Today, Sunesis Pharmaceuticals, Inc. released updates on its pivotal Phase 3 VALOR trial of vosaroxin, the company’s lead drug candidate…
Blog
Ivanhoe Energy Inc. (IVAN) Reports Successful Natural Gas Well in China
Ivanhoe Energy Inc. reported the successful completion of a natural gas well at the company’s properties in China. Ivanhoe Energy…
American Surgical Holdings, Inc. (ASRG.OB) Enters Into Definitive Merger Agreement
American Surgical Holdings, Inc. announced yesterday that they entered into a definitive merger agreement. With the agreement, American Surgical will…
Omnicity Corp. (OMCY.OB) Releases First Quarter Financial Results
The Midwest's largest and fastest growing fixed Wireless Internet Service Provider, Omincity Corp., has released its first quarter financial results…
Simulated Environment Concepts, Inc. (SMEV.PK) SpaCapsule to be Featured in Hammacher-Schlemmer and FrontGate Publications
Simulated Environment Concepts, the manufacturer and developer of medical, aesthetic and wellness equipment, today announced that its flagship SpaCapsule has…
True 2 Beauty, Inc. (TRTB.PK) Ramps Up Production
To get an idea of the anticipated growth of True 2 Beauty, makers and distributors of Libigrow and other sexual…
Pernix Therapeutics Holdings, Inc. (PTX) Forms Joint Venture with SEEK to Develop Cough Treatment
Pernix Therapeutics Holdings Inc., an integrated specialty pharmaceutical company focused primarily on the pediatric market, today announced its new joint…
Synthesis Energy Systems Inc. (SYMX) Completes Gasification Testing, Moves toward Licensing Agreement
Synthesis Energy Systems Inc., a global energy and gasification technology company, today announced it has completed a commercial-scale demonstration test…
EarthLink, Inc. (ELNK) Moves to Acquire One Comm, Adjusts Quarterly Dividend Rate
EarthLink, www.earthlink.net – the widely-known IP infrastructure and services provider, reported a definitive merger agreement to acquire integrated telecom firm,…
BrainStorm Cell Therapeutics, Inc. (BCLI.OB) Gets Funding for Its Adult Stem Cell Technology
BrainStorm Cell Therapeutics Inc. is a leading developer of adult stem cell therapeutic products. The company holds the global rights…